Not applicableStudy completedNCT05617209
What this trial is testing
In Vitro Correction of Thrombin Generation by Concizumab (Anti-TFPI) for Severe Hemophilia Patients
Who this might be right for
Hemophilia
Centre Hospitalier Universitaire de Saint Etienne 20